Marinomed Biotech entwickelt Produkte im Bereich Atemwegs- und Augenerkrankungen, die auf einer patentgeschützten Technologieplattformen basieren. Der Firmensitz des Unternehmen befindet sich Korneuburg in der Nähe von Wien.
INVESTOR TERMSHEET
93Z

Marinomed Biotech
#BGFL Mood: Neutral · #BGFL-Indicator: Hold · Review date: -
LEI: 529900GN3B1EN80XF405
SECTOR: Gesundheit SUB-SECTOR: Biotechnologie
NAME
Marinomed Biotech
WKN
A2N9MM
ISIN
ATMARINOMED6
TICKER
MBG
INDEX
EXCHANGE
Frankfurt
Made with ❤ von BGFL

The most important master data on the respective share as well as classic valuation ratios - from the price/earnings ratio (P/E ratio) to the dividend yield. For additional fundamental indicators, we recommend our interactive Fundamental Scanner.

About Marinomed Biotech
Company Snapshot
Company
Name:
Marinomed Biotech
Legal Entity Type:
AG
Business Year:
31.12
Number of employees:
47
Trading Segment:
Freiverkehr
Fact & Figures
Number of shares:
1.778.333
Marketcap (Mio. €):
25,43
Freefloat:
65,80
Enterprise value:
48,57
KPI Snapshot
KGV 2025:
0,00
KGV 10 Years Ø:
0,00
Yield:
0,00
Dividend Yield 10 Year Ø%:
0,00
KBV:
-2,51
KBV 10 Year Ø:
0,00

All master data on the individual companies is maintained by boersengefluester.de (BGFL) itself: From the number of shares and the free float to all forward-looking information. And of course we also provide all estimates of dividends and other key operating figures such as sales, earnings and cash flow.

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2024          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL